Duration of antiplatelets | All-cause mortality | CVD mortality | Non-CVD mortality | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Event No | Crude HR (95% CI) | p value | Adjusted HRb (95% CI) | p value | Event No | Crude HR (95% CI) | p value | Adjusted HRb (95% CI) | p value | Event No | Crude HR (95% CI) | p value | Adjusted HRb (95% CI) | p value | |
Non-persistent (< 6 months) (n = 321) | 173 | 2.35 (1.90-2.91) | 0.000 | 2.13 (1.72-2.65) | 0.000 | 63 | 2.40 (1.68-3.42) | 0.000 | 2.26 (1.57-3.24) | 0.000 | 110 | 2.33 (1.78-3.03) | 0.000 | 2.06 (1.57-2.70) | 0.000 |
Persistent (≥ 6 months) (n = 556) | 168 | Reference | Reference | 59 | Reference | Reference | 109 | Reference | Reference |